Literature DB >> 4271302

Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma.

A Yagoda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4271302     DOI： 10.1002/1097-0142(197311)32:5<1131::aid-cncr2820320519>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

Authors:  Michael J Morris; Timothy Akhurst; Steven M Larson; Marisa Ditullio; Elaina Chu; Karen Siedlecki; David Verbel; Glenn Heller; W Kevin Kelly; Susan Slovin; Lawrence Schwartz; Howard I Scher
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

Review 2.  Novel tracers and their development for the imaging of metastatic prostate cancer.

Authors:  Andrea B Apolo; Neeta Pandit-Taskar; Michael J Morris
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

3.  [Ultrastructural findings in carcinoma of the prostate after combined endocrine and radiation treatment].

Authors:  H Kastendieck; E Altenähr; P Burchardt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

4.  Cytostatic therapy, its value and indications in the management of prostatic carcinoma.

Authors:  J Hübler; D Frang
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

5.  Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.

Authors:  A V Schally; T W Redding
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer.

Authors:  Che-Kai Tsao; Sonia Seng; William K Oh; Matthew D Galsky
Journal:  Clin Med Insights Oncol       Date:  2011-05-24

Review 7.  Role of chemotherapy in prostate cancer.

Authors:  Rita Nader; Joelle El Amm; Jeanny B Aragon-Ching
Journal:  Asian J Androl       Date:  2018 May-Jun       Impact factor: 3.285
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.